NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,639,692,000
EV to revenue ratio (TTM)
291.72
EV to ebitda
27.63
Financial Performance
Revenue (TTM)
7,121,000
Gross profit (TTM)
7,121,000
EBITDA
-244,163,008
Profitability
Operating margin (TTM)
-1,753.00%
Profit margin
0.00%
Return on assets (TTM)
-20.10%
Return on equity (TTM)
-36.80%
Per Share Metrics
Revenue per share (TTM)
0.06
EPS
-2.16
Diluted EPS (TTM)
-2.16
Book value
5.37
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
119.05
PEG ratio
Price to sales ratio (TTM)
379.04
Price to book ratio (TTM)
4.294
Growth
Quarterly earnings growth (YoY)
-80.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
12
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.094